Original Research
Published on 07 Sep 2021
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 06 Sep 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 02 Sep 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 31 Aug 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 31 Aug 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 31 Aug 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 30 Aug 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 30 Aug 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 27 Aug 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 26 Aug 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 24 Aug 2021
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 24 Aug 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 23 Aug 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 23 Aug 2021
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 18 Aug 2021
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 18 Aug 2021
in Gastrointestinal and Hepatic Pharmacology
![Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives](https://www.frontiersin.org/files/myhome article library/691234/691234_Thumb_400.jpg)
